Wall Street Zen upgraded shares of Cooper Companies (NASDAQ:COO – Free Report) from a hold rating to a buy rating in a research note published on Saturday morning,Wall Street Zen reports.
COO has been the subject of a number of other research reports. Stifel Nicolaus set a $70.00 price objective on shares of Cooper Companies and gave the company a “buy” rating in a report on Thursday, September 10th. Zacks Research cut Cooper Companies from a “hold” rating to a “strong sell” rating in a research report on Friday, September 11th. Robert W. Baird set a $61.00 target price on Cooper Companies and gave the stock a “neutral” rating in a research note on Thursday, September 10th. Mizuho set a $75.00 target price on Cooper Companies and gave the company an “outperform” rating in a research report on Thursday, September 10th. Finally, Citigroup reaffirmed a “neutral” rating and set a $60.00 price objective (down from $80.00) on shares of Cooper Companies in a report on Thursday, September 10th. Four equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $68.60.
View Our Latest Research Report on COO
Cooper Companies Trading Down 2.5%
NASDAQ COO opened at $58.84 on Friday. The company has a market capitalization of $11.19 billion, a PE ratio of 20.08, a P/E/G ratio of 2.31 and a beta of 0.83. The company has a fifty day moving average of $58.36 and a 200 day moving average of $67.65. Cooper Companies has a 1 year low of $51.01 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the company earned $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Research analysts forecast that Cooper Companies will post 4.53 earnings per share for the current year.
Cooper Companies declared that its Board of Directors has approved a share buyback program on Wednesday, September 9th that authorizes the company to buy back $3 billion in outstanding shares. This buyback authorization authorizes the medical device company to reacquire up to 22.7% of its shares through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its shares are undervalued.
Insiders Place Their Bets
In other news, Director Paul A. Keel acquired 4,701 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The stock was purchased at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the completion of the transaction, the director owned 4,701 shares in the company, valued at approximately $249,999.18. This trade represents a ? increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Lawrence Kurzius acquired 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 16th. The stock was acquired at an average price of $54.93 per share, for a total transaction of $549,300.00. Following the completion of the acquisition, the director directly owned 31,099 shares of the company’s stock, valued at $1,708,268.07. The trade was a 47.40% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 34,701 shares of company stock valued at $1,880,039 in the last three months. 2.08% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Algert Global LLC acquired a new stake in shares of Cooper Companies in the 2nd quarter worth approximately $7,655,000. Bank of America Corp DE purchased a new position in Cooper Companies in the 2nd quarter valued at approximately $144,125,000. BlackRock Inc. acquired a new position in Cooper Companies during the second quarter worth $1,077,762,000. National Pension Service raised its holdings in Cooper Companies by 9,314.0% during the second quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock worth $37,730,000 after purchasing an additional 520,560 shares during the last quarter. Finally, Phoenix Financial Ltd. acquired a new position in Cooper Companies during the third quarter worth $724,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.
About Cooper Companies
CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.
Further Reading
- Five stocks we like better than Cooper Companies
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
